Indivior Pharmaceuticals (INDV) EBIT Margin Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) EBIT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 304.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -650.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 111.00
10 Indivior Pharmaceuticals 1.00 Bn 829.65 Mn 277.00 Mn 1,841.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,841.00
Dec 31, 2025 724.00
Sep 30, 2025 229.00
Jun 30, 2025 6,331.00
Mar 31, 2025 -160.00